Actively Recruiting

Age: 18Years +
All Genders
ID06667869

Multiparameter Monitoring System for Sedation in Critically Ill ICU Patients (ROMANTIC)

Led by Pontificia Universidad Catolica de Chile · Updated on 2025-06-08

80

Participants Needed

2

Research Sites

23 weeks

Total Duration

On this page

Sponsors

P

Pontificia Universidad Catolica de Chile

Lead Sponsor

A

Agencia Nacional de Investigación y Desarrollo

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are investigating a new multiparameter monitoring system called ROMANTIC to improve sedation management in critically ill patients in intensive care units (ICUs). Sedation dosing is crucial to avoid complications like delirium, prolonged ventilation, and increased mortality. Current sedation monitoring methods, such as clinical scales (RASS/SAS), have limitations especially when patients are unresponsive or using neuromuscular blockers. ROMANTIC aims to use machine learning with various patient data—including demographic, pharmacological, hemodynamic, respiratory, and EEG information—to better classify sedation status into underdosing, appropriate dosing, or overdosing categories. The study has two phases: first, a prospective observational cohort study collecting comprehensive data from ICU patients receiving sedation and mechanical ventilation for over 24 hours. Data include vital signs, sedation drugs (Fentanyl with Propofol or Midazolam), EEG signals, and clinical sedation scales recorded hourly. Two or three data collection windows occur per patient, starting after intubation, during sedation suspension, and if needed, during re-sedation. The second phase uses this data to develop and test a machine learning model that informs ICU staff about patients' sedation depth. Participants will be monitored through detailed clinical and laboratory assessments during their ICU stay, including sedation scales, EEG, hemodynamics, respiratory parameters, pain scores, neuromuscular blockade tests, and blood samples for drug concentrations. Delirium will be assessed twice daily after awakening. The primary outcome is time to extubation after sedation suspension, with secondary outcomes including length of ICU stay, duration of mechanical ventilation, incidence of ICU delirium, and serum sedative levels. The study's goal is to create a tool that helps non-specialized staff determine sedation levels more accurately and efficiently, potentially improving patient outcomes and ICU resource use.

CONDITIONS

Brief Title

multipaRameter mOnitoring systeM for sedAtion iNThe ICu

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients admitted to adult critical care units
  • Individuals over 18 years old
  • Requiring sedation for more than 24 hours
  • Patients needing mechanical ventilation for more than 24 hours
Not Eligible

You will not qualify if you...

  • Patients with neurological pathology causing mechanical ventilation (including recovered cardiocirculatory arrest, fulminant liver failure, and neurocritical conditions except subdural hematomas or subarachnoid hemorrhages)
  • Pregnancy
  • Presence of psychiatric or intellectual disability prior to hospitalization
  • Drug dependency
  • History of chronic liver damage with hepatic encephalopathy
  • Second period of mechanical ventilation during hospitalization
  • Early limitation of therapeutic effort
  • Patients under 18 years old

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - Up to 100 days during ICU hospitalization

Participants are observed while receiving sedation and mechanical ventilation in the ICU. Data including clinical, demographic, pharmacological, hemodynamic, ventilatory, EEG, pain, and neuromuscular blockade variables are collected during two or three data recording windows to assess sedation levels.

Continuous monitoring with data collection during 2 to 3 windows of approximately 6 hours each

Long-term Monitoring

Duration - Up to 5 days post-extubation

After sedation is suspended and participants awaken, delirium is assessed twice daily for up to 5 days post-extubation using the CAM-ICU tool by trained nursing staff.

Twice daily assessments (AM/PM) for up to 5 days

Trial Site Locations

Total: 2 locations

1

Hospital Dr. Sotero del Rio

Santiago, Metropolitana de Santiago, Chile, 7700642

Not Yet Recruiting

2

Hospital Clínico Pontificia Universidad Católica de Chile

Santiago, Santiago Metropolitan, Chile, 8330024

Actively Recruiting

Loading map...

Research Team

J

Juan C. Pedemonte, M.D.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Comparison of Remimazolam Besylate and Propofol Sedation Dur...

Colonic Polyp

Actively Recruiting

1 location

Effect of Goal-directed Analgesia and Sedation Using EEG Der...

Sedation Complication

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Patients' recollections of stressful experiences while receiving prolonged mechanical ventilation in an intensive care unit.

Armando J Rotondi, Lakshmipathi Chelluri, Carl Sirio...

https://pubmed.ncbi.nlm.nih.gov/11940739

A systematic review of the impact of sedation practice in the ICU on resource use, costs and patient safety.

Daniel L Jackson, Clare W Proudfoot, Kimberley F Cann...

https://pubmed.ncbi.nlm.nih.gov/20380720

Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU.

John W Devlin, Yoanna Skrobik, Céline Gélinas...

https://pubmed.ncbi.nlm.nih.gov/30113379